Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Changes in Cholinesterase Activity in Blood of Adolescent with Metabolic Syndrome after Supplementation with Extract from Aronia melanocarpa.

Duchnowicz P, Ziobro A, Rapacka E, Koter-Michalak M, Bukowska B.

Biomed Res Int. 2018 Mar 26;2018:5670145. doi: 10.1155/2018/5670145. eCollection 2018.

2.

Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease.

Olszewska-Banaszczyk M, Jackowska P, Gorzelak-Pabiś P, Pytel E, Koter-Michalak M, Broncel M.

Pharmacol Rep. 2018 Apr;70(2):258-262. doi: 10.1016/j.pharep.2017.11.004. Epub 2017 Nov 20.

PMID:
29475008
3.

The in vitro comparative study of the effect of BPA, BPS, BPF and BPAF on human erythrocyte membrane; perturbations in membrane fluidity, alterations in conformational state and damage to proteins, changes in ATP level and Na+/K+ ATPase and AChE activities.

Maćczak A, Duchnowicz P, Sicińska P, Koter-Michalak M, Bukowska B, Michałowicz J.

Food Chem Toxicol. 2017 Dec;110:351-359. doi: 10.1016/j.fct.2017.10.028. Epub 2017 Oct 25.

PMID:
29079494
4.

Decreased activity of butyrylcholinesterase in blood plasma of patients with chronic obstructive pulmonary disease.

Sicinska P, Bukowska B, Pajak A, Koceva-Chyla A, Pietras T, Nizinkowski P, Gorski P, Koter-Michalak M.

Arch Med Sci. 2017 Apr 1;13(3):645-651. doi: 10.5114/aoms.2016.60760. Epub 2016 Jun 20.

5.

Tolerance of monocytes and macrophages in response to bacterial endotoxin.

Wiśnik E, Pikus E, Duchnowicz P, Koter-Michalak M.

Postepy Hig Med Dosw (Online). 2017 Mar 7;71(0):176-185. Review.

6.

Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease.

Pytel E, Bukowska B, Koter-Michalak M, Olszewska-Banaszczyk M, Gorzelak-Pabiś P, Broncel M.

Pharmacol Rep. 2017 Feb;69(1):150-155. doi: 10.1016/j.pharep.2016.09.016. Epub 2016 Sep 21.

PMID:
27923158
7.

The Effect of Combined Ezetimibe/Atorvastatin Therapy vs. Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease: A Pilot Study.

Jackowska P, Pytel E, Koter-Michalak M, Olszewska-Banaszczyk M, Legęza A, Broncel M.

Adv Clin Exp Med. 2016 May-Jun;25(3):433-9. doi: 10.17219/acem/34791.

8.

The Impact of Glyphosate, Its Metabolites and Impurities on Viability, ATP Level and Morphological changes in Human Peripheral Blood Mononuclear Cells.

Kwiatkowska M, Jarosiewicz P, Michałowicz J, Koter-Michalak M, Huras B, Bukowska B.

PLoS One. 2016 Jun 9;11(6):e0156946. doi: 10.1371/journal.pone.0156946. eCollection 2016.

9.

[PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective].

Wiśnik E, Ryksa M, Koter-Michalak M.

Postepy Hig Med Dosw (Online). 2016 Apr 13;70:280-94. Review. Polish.

10.

Intensive statin therapy, used alone or in combination with ezetimibe, improves homocysteine level and lipid peroxidation to a similar degree in patients with coronary artery diseases.

Pytel E, Jackowska P, Chwatko G, Olszewska-Banaszczyk M, Koter-Michalak M, Kubalczyk P, Broncel M.

Pharmacol Rep. 2016 Apr;68(2):344-8. doi: 10.1016/j.pharep.2015.08.019. Epub 2015 Sep 28.

PMID:
26922537
11.

Oxidative stress and damage to erythrocytes in patients with chronic obstructive pulmonary disease--changes in ATPase and acetylcholinesterase activity.

Bukowska B, Sicińska P, Pająk A, Koceva-Chyla A, Pietras T, Pszczółkowska A, Górski P, Koter-Michalak M.

Biochem Cell Biol. 2015 Dec;93(6):574-80. doi: 10.1139/bcb-2015-0066. Epub 2015 Aug 18.

PMID:
26369587
12.

[Supplementation with omega fatty acids in various diseases].

Sicińska P, Pytel E, Kurowska J, Koter-Michalak M.

Postepy Hig Med Dosw (Online). 2015 Jul 24;69:838-52. Review. Polish.

13.

[The use of various diet supplements in metabolic syndrome].

Sicińska P, Pytel E, Maćczak A, Koter-Michalak M.

Postepy Hig Med Dosw (Online). 2015 Jan 9;69:25-33. Review. Polish.

14.

[Increased level of lipid peroxidation products and disturbances in oxidation-reduction balance in erythrocytes from patients suffering from systemic sclerosis, who are chronically treated with vitamin E].

Dworniak K, Duchnowicz P, Koter-Michalak M, Dziankowska-Bartkowiak B, Gerlicz Z, Waszczykowska E, Broncel M.

Pol Merkur Lekarski. 2013 Aug;35(206):85-8. Polish.

PMID:
24052987
15.

Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients.

Pytel E, Olszewska-Banaszczyk M, Koter-Michalak M, Broncel M.

Biochem Cell Biol. 2013 Oct;91(5):315-8. doi: 10.1139/bcb-2013-0027. Epub 2013 May 30.

PMID:
24032681
16.

Effect of safeners on damage of human erythrocytes treated with chloroacetamide herbicides.

Bernasinska J, Duchnowicz P, Koter-Michalak M, Koceva-Chyla A.

Environ Toxicol Pharmacol. 2013 Sep;36(2):368-77. doi: 10.1016/j.etap.2013.04.010. Epub 2013 Apr 30.

PMID:
23732483
17.

Oxidative damages in erythrocytes of patients with metabolic syndrome.

Ziobro A, Duchnowicz P, Mulik A, Koter-Michalak M, Broncel M.

Mol Cell Biochem. 2013 Jun;378(1-2):267-73. doi: 10.1007/s11010-013-1617-7. Epub 2013 Mar 21.

18.

Effect of polyphenols extracts from Brassica vegetables on erythrocyte membranes (in vitro study).

Duchnowicz P, Bors M, Podsędek A, Koter-Michalak M, Broncel M.

Environ Toxicol Pharmacol. 2012 Nov;34(3):783-90. doi: 10.1016/j.etap.2012.09.008. Epub 2012 Sep 23.

19.

In vivo influence of extract from Aronia melanocarpa on the erythrocyte membranes in patients with hypercholesterolemia.

Duchnowicz P, Nowicka A, Koter-Michalak M, Broncel M.

Med Sci Monit. 2012 Sep;18(9):CR569-74.

20.

Disorders of erythrocyte structure and function in hypertensive patients.

Pytel E, Duchnowicz P, Jackowska P, Wojdan K, Koter-Michalak M, Broncel M.

Med Sci Monit. 2012 Aug;18(8):BR331-336.

Supplemental Content

Loading ...
Support Center